Growth trajectory Target international expansion and leadership changes to position SyntheticMR as a global partner for advanced neuroimaging solutions, focusing on regions with growing healthcare investment such as USA, Europe, Japan and India.

Advanced offerings Leverage SyMRI NEURO and 3D capabilities to address demand for fast, quantitative brain imaging and automated biomarker analysis, highlighting time savings and objective decision support to radiology departments and imaging centers.

Acquisition leverage Capitalize on the Combinostics US acquisition to cross-sell integrated brain imaging analytics, promoting combined noninvasive quantitative tools to hospitals seeking comprehensive neuroimaging solutions.

Strategic partnerships Engage with flagship radiology and health IT vendors, academic centers, and physician networks to deploy standardized protocols, expand sales channels, and accelerate adoption of SyMRI across hospital systems.

Financial & resilience Emphasize scalable pricing and ROI for mid-market hospitals and clinics, supported by a growing revenue base and international sales footprint, to drive expansion in mid-sized health systems and imaging groups.